Tobias Walbert
Neurology · Detroit, MINPI 1952511933
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $40,741 of the $56,396 with a category attached, or 72.2%. 5 manufacturers reported payments, led by Novocure Inc. at 34.6% of the total. 2025 is the largest year on record at $22,303, 4.4 times the $5,117 reported in 2019. Among neurology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $1253.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$20K
- Springworks Therapeutics, Inc.$19K
- AstraZeneca$18K
- Servier Pharmaceuticals LLC$231
- Merck$64
Across 66 payments — averaging $6572.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Servier Bioinnovation$240K
- E.r. Squibb & Sons, L.L.C.$85K
- Springworks Therapeutics, Inc.$31K
- Servier Pharmaceuticals LLC$29K
- Agios Pharmaceuticals, Inc.$28K
- Beigene, Ltd.$14K
- plus $6K from 1 others
What the payments were for
- Consulting fees$40,74172%
- Speaking & faculty fees$13,01323%
- Travel & lodging$2,0424%
- Food & beverage$6011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 7 | $19,500 |
| Springworks Therapeutics, Inc. | 17 | $18,790 |
| AstraZeneca(2 entities) | 18 | $17,811 |
| Servier Pharmaceuticals LLC | 2 | $231 |
| Merck | 1 | $64 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$56,396 in reported general payments places this provider in the 90th percentile of 652 neurology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 96 | $3,256 |
| Lacosamide | 26 | $2,319 |
| Lamotrigine | 25 | $1,049 |
| Dexamethasone | 17 | $355 |
| Topiramate | 12 | $150 |
Paid to pharmacies, not to this prescriber.
Other neurology in Detroit
- Bisena BulicaDetroit$900K
- Evanthia BernitsasDetroit$255K
- Andrew RussmanDetroit$118K
- Alex CheblDetroit$68K
- Panayiotis VarelasDetroit$48K
- Aaron EllenbogenFarmington Hills$1.6M
- Matthew HoltzmanWayne$1.4M
- Richard TroschFarmington Hills$1.2M
- Wade CooperAnn Arbor$991K
- Julie BurnhamMount Clemens$836K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.